APA

Zent C. S., Mathieu C., Claxton D. F., Zhang D. E., Tenen D. G., Rowley J. D. & Nucifora G. (19960314). The chimeric genes AML1/MDS1 and AML1/EAP inhibit AML1B activation at the CSF1R promoter, but only AML1/MDS1 has tumor-promoter properties. : Proceedings of the National Academy of Sciences of the United States of America.

Chicago

Zent C S, Mathieu C, Claxton D F, Zhang D E, Tenen D G, Rowley J D and Nucifora G. 19960314. The chimeric genes AML1/MDS1 and AML1/EAP inhibit AML1B activation at the CSF1R promoter, but only AML1/MDS1 has tumor-promoter properties. : Proceedings of the National Academy of Sciences of the United States of America.

Harvard

Zent C. S., Mathieu C., Claxton D. F., Zhang D. E., Tenen D. G., Rowley J. D. and Nucifora G. (19960314). The chimeric genes AML1/MDS1 and AML1/EAP inhibit AML1B activation at the CSF1R promoter, but only AML1/MDS1 has tumor-promoter properties. : Proceedings of the National Academy of Sciences of the United States of America.

MLA

Zent C S, Mathieu C, Claxton D F, Zhang D E, Tenen D G, Rowley J D and Nucifora G. The chimeric genes AML1/MDS1 and AML1/EAP inhibit AML1B activation at the CSF1R promoter, but only AML1/MDS1 has tumor-promoter properties. : Proceedings of the National Academy of Sciences of the United States of America. 19960314.